CLRB7:15 AMCellectar Biosciences Reports Second Quarter 2026 Financial Results and Provides Corporate UpdatesPresentation / Abstract • Phase 2cellectar.com
CLRB8:05 AMCellectar Biosciences to Report Second Quarter Financial Results and Host a Conference Call on Thursday, August 13, 2026cellectar.com
CLRB7:30 AMCellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancerscellectar.com
CLRB8:05 AMCellectar Biosciences to Highlight Compelling New Efficacy Data from Phase 2b CLOVER WaM Study of Iopofosine I 131 in r/r Waldenström Macroglobulinemia at the American Society of Clinical Oncology Annual MeetingPresentation / Abstract • Phase 2ASCO poster presentation Mon, Jun 1, 2026, 9:00 AM CDTGcellectar.com